First Oral Therapy for Rare Adrenal Gland Tumors Gets Green Light From FDA

(MedPage Today) — The FDA has expanded the approval of belzutifan (Welireg) to include certain types of pheochromocytoma or paraganglioma (PPGL) in adults and children.
The action establishes belzutifan as the only approved oral therapy for PPGL…

Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/115582

Author :

Publish date : 2025-05-14 20:17:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

First Oral Therapy for Rare Adrenal Gland Tumors Gets Green Light From FDA

Backup Drug Gains Footing for Resistant Hypertension

FDA OKs New Drug for Lung Cancer With c-Met Overexpression

Related Posts

Sleep and Alzheimer’s; NIH Cuts to Brain Research; Novel CTE Report

Physical Activity and Rehabilitation in Duchenne Muscular Dystrophy

RFK Jr.’s Mass Firings Likely Unlawful and Must Be Halted, Judge Says

NHS Access Issues Driving Down Childhood Vaccine Uptake

Most on Wegovy a Year Later; Food Label Weight Stigma; Make Your Own GLP-1 Drugs?

Proton Pump Inhibitors and Hypertension; AI Fetal Cardiac Scans; ‘Work Diet’

Sleep and Alzheimer’s; NIH Cuts to Brain Research; Novel CTE Report

Physical Activity and Rehabilitation in Duchenne Muscular Dystrophy

RFK Jr.’s Mass Firings Likely Unlawful and Must Be Halted, Judge Says

NHS Access Issues Driving Down Childhood Vaccine Uptake

Most on Wegovy a Year Later; Food Label Weight Stigma; Make Your Own GLP-1 Drugs?

Proton Pump Inhibitors and Hypertension; AI Fetal Cardiac Scans; ‘Work Diet’

Fixable Factors Help Drive Disparities in Access to COVID Treatment

A Neanderthal-shaped skull may explain why some people get headaches

Categories

Archives